Skip to main content
WGS
NASDAQ Industrial Applications And Services

Directors Casdin and Meister's Funds Acquire Another $21.4M in GeneDx Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$47.024
Mkt Cap
$1.405B
52W Low
$32.21
52W High
$170.87
52W Position info
46% above low
Off High info
72% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

WGS sits 46% above its 52-week low of $32.21.

Summary

Funds associated with directors Eli Casdin and Keith Meister continued to accumulate GeneDx Holdings Corp. stock, purchasing an additional $21.4 million in open market transactions. This follows recent large insider buys and occurs after the company's Q1 earnings miss and reduced guidance.


Key Events · Ownership and Investor Activity · WGS

  • Significant Insider Accumulation

    Funds managed by directors Eli Casdin and Keith Meister acquired 500,000 shares of GeneDx Holdings Corp. Class A Common Stock through open market purchases.

  • Substantial Investment

    The total value of these recent purchases, made between May 18-20, 2026, amounts to approximately $21.45 million.

  • Post-Earnings Conviction

    These purchases follow the company's recent Q1 earnings report (May 4, 2026) which included a significant net loss and reduced full-year guidance, suggesting strong insider confidence despite recent challenges.

  • Increased Beneficial Ownership

    Eli Casdin's beneficial ownership increased to 13.7% and Keith Meister's to 17.9% of the outstanding shares.


Analysis · WGS · Industrial Applications And Services

This Schedule 13D/A filing reveals a continuation of significant insider buying by entities associated with directors Eli Casdin and Keith Meister. The acquisition of an additional $21.45 million in shares, representing over 1.5% of the company's market capitalization, demonstrates strong conviction. This is particularly notable as these purchases occurred in the days following the company's Q1 earnings report, which included a larger-than-expected net loss and a reduction in full-year revenue guidance. The sustained accumulation by these key insiders, despite recent negative news, suggests a belief in the company's long-term prospects and could be interpreted as a vote of confidence.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WGS was trading at $47.02 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $32.21 to $170.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WGS - Latest Insights

WGS
Nov 10, 2026, 7:08 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $58.00
Real-time Price: $52.02 info
Change: -$5.98 (-10%) info
Market Cap: $1.529B info
WGS
Nov 09, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $59.00
Real-time Price: $52.02 info
Change: -$6.98 (-12%) info
Market Cap: $1.529B info
WGS
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $65.65
Real-time Price: $52.02 info
Change: -$13.63 (-21%) info
Market Cap: $1.529B info
WGS
Aug 03, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.01
Real-time Price: $52.02 info
Change: -$24.99 (-32%) info
Market Cap: $1.529B info
WGS
Aug 03, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $62.47
Real-time Price: $52.02 info
Change: -$10.45 (-17%) info
Market Cap: $1.529B info